Copyright
©The Author(s) 2016.
World J Hepatol. Nov 8, 2016; 8(31): 1295-1308
Published online Nov 8, 2016. doi: 10.4254/wjh.v8.i31.1295
Published online Nov 8, 2016. doi: 10.4254/wjh.v8.i31.1295
AUD (DSM-5) |
In the past year[2], have you1 |
Had times when you ended up drinking more, or longer than you intended? |
More than once wanted to cut down or stop drinking, or tried to, but couldn’t? |
Spent a lot of time drinking? Or being sick or getting over the aftereffects? |
Experienced craving - a strong need, or urge, to drink? |
Found that drinking or being sick from drinking often interfered with taking care of your home or family? Or caused job troubles? Or school problems? |
Continued to drink even though it was causing trouble with your family or friends? |
Given up or cut back on activities that were important or interesting to you, or gave you pleasure, in order to drink? |
More than once gotten into situations while or after drinking that increased your chances of getting hurt (such as driving, swimming, using machinery, walking in a dangerous area, or having unsafe sex)? |
Continued to drink even though it was making you feel depressed or anxious or adding to another health problem? Or after having had a memory blackout? |
Had to drink much more than you once did to get the effect you want? Or found that your usual number of drinks had much less effect than before? |
Found that when the effects of alcohol were wearing off, you had withdrawal symptoms, such as trouble sleeping, shakiness, irritability, anxiety, depression, restlessness, nausea, or sweating? Or sensed things that were not there? |
Risky alcohol use[178] |
Drinking more than the recommended amount by the National Institute on Alcohol Abuse and Alcoholism |
> 14 drinks per week of > 4 drinks on any day for men |
> 7 drinks per week or > 3 drinks on any day for women or men > 65 yr |
Problem drinking |
Use of alcohol accompanied by alcohol-related consequences but not meeting criteria for AUD |
Condition | Intervention |
Unhealthy alcohol use | Brief intervention |
Motivational interviewing | |
AUD | Hospital detoxification |
Individual and group therapy | |
Approved pharmacological treatments: | |
Disulfiram | |
Acamprosate | |
Naltrexone | |
Nalmefene | |
Investigational treatments: | |
Baclofene | |
Topiramate | |
Gabapentin |
Ref. | Setting | Non-invasive method | Method for detecting alcohol consumption | Finding |
Lieber et al[69] | VA studies (2) of alcoholic liver disease | APRI1 | Average alcohol intake | Low sensitivity and specificity of APRI in comparison to liver biopsy, especially in subjects with HCV |
Chaudhry et al[169] | HIV Hopkins clinical cohort | APRI | Past 6-mo hazardous drinking | No effect of alcohol on APRI values in HCV/HIV co-infection |
Blackard et al[170] | WIHS cohort | FIB-42 | Recent drinking | No association between alcohol intake and FIB-4 values in HCV/HIV co-infection |
Muga et al[171] | AUD patients admitted for detoxification | FIB-4 | Past 6-mo unhealthy drinking | No association between FIB-4 and alcohol use in HCV/HIV co-infection |
Fuster et al[173] | HIV-live cohort | FIB-4 and APRI | LDH | No association between LDH and liver fibrosis measured with FIB-4 or APRI |
Lim et al[174] | VACS cohort | FIB-4 | AUDIT-C3 | Advanced liver fibrosis correlated with alcohol use |
- Citation: Fuster D, Sanvisens A, Bolao F, Rivas I, Tor J, Muga R. Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections. World J Hepatol 2016; 8(31): 1295-1308
- URL: https://www.wjgnet.com/1948-5182/full/v8/i31/1295.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i31.1295